Global Health Ltd. Earnings/Conference Calls

Sir Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript of the Earnings Conference Call held on Monday, May 29, 2023, hosted by Motilal Oswal, for the Quarter & Financial Year ended March 31, 2023 is enclosed herewith. Thank You

pdf

Global Health Ltd.

29 May 2023

1261.60

0.96%

Trendlyne Earnings Call

Global Health Ltd (Medanta) Results Earnings Call for Q4FY23

Conference Call with Global Health Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.

pdf

Global Health Ltd.

29 May 2023

1261.60

0.96%

Earnings Call

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Dear Sir(s), Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the below link of Audio recording of Earnings Conference Call held on Monday, May 29, 2023 hosted by Motilal Oswal , for the Quarter & Financial Year ended March 31, 2023: https://d3b6u46udi9ohd.cloudfront.net/wp-content/uploads/2023/02/29140404/Medanta-Earnings-Call-Audio-Q4-FY23.mp3 This is for your information and record.

pdf

Global Health Ltd.

27 May 2023

1261.60

0.96%

Investor Presentation

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Dear Sir(s), Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of Investor Presentation for Investors, on the Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023. Kindly take the above on record.

pdf

Global Health Ltd.

20 Feb 2023

1261.60

0.96%

Earnings Call

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the below link of transcript of Earnings Conference Call held on Tuesday, February 14, 2023 hosted by JM Financials, for the Quarter III & Nine Months ended December 31, 2022 Results of the Company. https://www.medanta.org/investor_relations/quarterly-financial-results/conference-call-transcript The Transcript is also attached herewith for your reference.

pdf

Global Health Ltd.

13 Feb 2023

1261.60

0.96%

Investor Presentation

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Dear Sir, Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the copy of Investor Presentation for the Quarter III & Nine Months ended December 31, 2022 financial results of the Company. Kindly take the above on record.

pdf

Global Health Ltd.

16 Dec 2022

1261.60

0.96%

Investor Presentation

Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Dear Sir, This is with reference to the intimation made by the Company vide its letter dated 15th December, 2022 bearing Ref No.-GHL/2022-23/EXCH/010. In this context, please find attached herewith a copy of presentation made thereat. Kindly take the above on record.

pdf

VOTE: Is Global Health Ltd. worth buying?

88 Votes:

Buy 78.41%

Sell 12.5%

Hold 9.09%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf